Immunoassay standards and measurement of clinical biomarkers using intra-assay calibration standards

Details for Australian Patent Application No. 2011215970 (hide)

Owner Bristol-Myers Squibb Company

Inventors Rhyne, Paul; Mapelli, Claudio; Wong, Oitak; Berisha, Flora; Neely, Robert John

Agent A J Park

Pub. Number AU-A-2011215970

PCT Pub. Number WO2011/100292

Priority 61/302,835 09.02.10 US

Filing date 9 February 2011

Wipo publication date 18 August 2011

International Classifications

G01N 33/68 Investigating or analysing materials by specific methods not covered by groups - involving proteins, peptides or amino acids

C07K 19/00 Hybrid peptides

G01N 33/531 Investigating or analysing materials by specific methods not covered by groups - Production of immunochemical test materials

Event Publications

20 September 2012 PCT application entered the National Phase

  PCT publication WO2011/100292 Priority application(s): WO2011/100292

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011215977-Process to remove product alcohol from a fermentation by vaporization under vacuum

2011215968-Thoracic aorta stent graft